NEW YORK (
) hit a new 52-week low Tuesday as it is currently trading at $8.91, below its previous 52-week low of $8.95 with 12,608 shares traded as of 9:40 a.m. ET. Average volume has been 226,400 shares over the past 30 days.
Syneron Medical has a market cap of $347.6 million and is part of the
industry. Shares are down 10.6% year to date as of the close of trading on Monday.
Syneron Medical Ltd., together with its subsidiaries, engages in the research, development, marketing, and sale of aesthetic medical products worldwide.
- Practice your ELOS trading strategies and win cash in our stock game.
TheStreet Ratings rates Syneron Medical as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and impressive record of earnings per share growth. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. You can view the full
or get investment ideas from our